TO THE EDITOR

We read the article titled “Review on radiological evolution of COVID-19 pneumonia using computed tomography” by Casartelli

[1] with keen interest. A chest computed tomography (CT) scan can be a useful diagnostic tool in a high-prevalence or pandemic situation, especially with clinical correlation. Risk stratification and assessing the progression of disease are also effective uses of CT chest imaging in coronavirus disease 2019 (COVID-19) patients. Given the global spread of COVID-19 and the magnitude of both direct and indirect effects of the disease, a CT scan of the chest can help in long-term prognostication in patients who survive.

And furthermore, the Prince had a nightingale, who could sing in such a mannerthat it seemed as though all sweet melodies dwelt in her little throat. So thePrincess was to have the rose, and the nightingale; and they were accordinglyput into large silver caskets, and sent to her.

He nodded to them, saying, It must be rather dull standing28 on the stairs; I would rather go inside! The halls blazed with lights; councillors and ambassadors were walking about in noiseless shoes carrying gold dishes

Multiple studies have concluded that with disease progression, certain initial CT findings in COVID-19 can evolve with a specific pattern and regularity. COVID-19 pneumonia-related changes seen on CT chest imaging typically progress rapidly, plateau, and subsequently start to resolve thereafter. Changes in CT imaging vary widely from six to seventeen days but typically stabilize within the first two weeks of COVID-19 pneumonia. In the short term, some of the features seem to recur, with scans mostly showing consolidations and ground-glass opacities (GGO). Besides GGO, chest CT characteristics that indicate the reparation, including subpleural, linear opacities, and fibrotic changes, were also reported. A sign termed “fishing net on trees” has also been reported. Some reports have also mentioned interseptal thickening and fibrous streaks[1,2]. Three weeks post-discharge, GGO and fibrous stripes have been seen, while after four weeks, mostly linear opacities remained. The “tinted” sign and bronchovascular bundle distortion have also been mentioned. The bronchovascular bundle distortion could possibly be a result of inflammatory destruction or subsegmental atelectasis. The latter two signs mentioned above may signify the gradual resolution of inflammation with re-expansion of alveoli based on previous reports. This review included reports with follow-up durations of up to four months[1].

In a study conducted by Pan

[3], two hundred nine patients with COVID-19 infection, who had been admitted to the hospital, undertook serial chest CT at three, seven, and twelve months. One-year CT chest follow-up revealed residual linear lesions, multiple areas of reticular opacities/cysts, and complete resolution in 12%, 13%, and 75%, respectively[3]. In another study conducted by Guan

[4], CT results of 69 patients who had COVID-19 infection were assessed in three different phases: Initial CT, peak CT, and CT prior to discharge. Peak CT in this study was the highest attenuation of the density without alteration in size during COVID-19 progression or the maximal size of lesion on CT which is the most common pattern. The intervals were closely correlated to lobe scores and CT appearances; the higher the lobe score, the longer the intervals. The lobe score was calculated according to the percentage of the lesion in one lobe with the zero equals to no lesion, one equals more than 0% to less than 25%, two equals 25% to less than 50%, three equals 50% to less than 75%, and four equals to 75% or more. While the utilization of lobe score may be beneficial, further studies are necessary to assess its effectiveness on a larger scale.

Chohan A and Taweesedt PT wrote the letter; Choudhury S wrote the letter; Franco R, Dadhwal R, Vakil AP and Taweesedt PT revised the letter.

This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

All authors declare no conflicts-of-interest related to this article.

FOOTNOTES

The duration of initial interval is inversely correlated with the amount of consolidations, air bronchograms, and irregular lines[3]. The intervals will be longer if irregular and reticular lines are seen on the peak CT and pre-discharge CT. After that, COVID-19 pneumonia lesions on the CT chest may resolve completely, while GGO, irregular and reticular lines may remain[3]. In a similar study conducted by Chen

[5], 41 patients were followed with chest CT during the hospital stay and at two weeks, one month, three months, six months, and one year after discharge. The study concluded that patients showed continuous improvement on lung CT scans during the 1-year follow-up time; however residual lesions (GGO and reticular patterns) may still be found, which are associated with lung volume parameters and risk of developing lung opacities[5]. Liu

[6] retrospectively evaluated chest CT follow-ups on 51 patients with COVID-19 performed on the day prior to discharge, two weeks postdischarge, and four weeks post-discharge. The results of this study indicated that changes seen were significantly reduced, including density reduction on follow-up scans as compared to the scans done at the time of discharge.

While CT scan of the chest is an effective tool in COVID-19 patients, the side effects to patients of repeat irradiation need to be kept in mind and the use of low dose CT to follow up these patients can be considered. In conclusion, CT scans of the chest are an effective diagnostic tool which can provide insight into the structural pathology of pulmonary disease, its progression, and its association with long-term effects. Future studies should be utilized to define its utility in determining long-term progression in patients with COVID-19 pneumonia.

Unlike the systematic review by Casartelli

[1], these results showed that 64.7% of discharged patients progressed to complete resolution of previously seen lung lesions at 4-wk follow-up, indicating that damaged lung tissue could heal in patients with COVID-19 pneumonia[5]. In another study conducted by Liu

[7], 41 patients diagnosed with COVID-19 were followed up after seven months with chest CT and cardiopulmonary exercise testing. The predominant chest CT patterns at seven months included parenchymal bands (41%), interlobular septal thickening (32%), and traction bronchiectasis (29%). Sixty-one percent of the patients achieved complete radiological resolution, while 29% went on to develop pulmonary fibrosis. Those patients who went on to develop fibrotic lung disease appeared to have an increased risk due to older age and comorbid conditions[7].

United States

Wang JJ

Asad Chohan 0000-0002-1801-9792; Saiara Choudhury 0000-0001-7225-4905; Rahul Dadhwal 0000-0001-6963-1466; Abhay P Vakil 0000-0003-4947-0233; Rene Franco 0000-0002-0684-7734; Pahnwat Tonya Taweesedt 0000-0002-5791-6920.

When I called for the contributions the next day, I discovered that almost everyone had forgotten. Except for Willard P. Franklin. The boy dug deep into his pants pockets as he strolled5 up to my desk. Carefully, he dropped two quarters into the small container.

But his sister did not keep quiet for long, and tore and pulled at the rich brocade as if she wanted to destroy it, stamping about and shouting angrily

A

Wang JJ

1 Casartelli C, Perrone F, Balbi M, Alfieri V, Milanese G, Buti S, Silva M, Sverzellati N, Bersanelli M. Review on radiological evolution of COVID-19 pneumonia using computed tomography.

2021; 13: 294-306 [PMID:34630915 DOI: 10.4329/wjr.v13.i9.294]

2 Mejía-Zambrano H. Radiological and functional pulmonary complications in patients recovered from COVID-19.

2021 [DOI: 10.54034/mic.e1217]

3 Pan F, Yang L, Liang B, Ye T, Li L, Liu D, Wang J, Hesketh RL, Zheng C. Chest CT Patterns from Diagnosis to 1 Year of Follow-up in Patients with COVID-19.

2022; 302: 709-719 [PMID: 34609153 DOI: 10.1148/radiol.2021211199]

4 Guan CS, Lv ZB, Li JJ, Du YN, Chen H, Cui T, Guo N, Chen BD, Xie RM. CT appearances, patterns of progression, and follow-up of COVID-19: evaluation on thin-section CT.

2021; 12: 73 [PMID: 34110540 DOI:10.1186/s13244-021-01019-0]

5 Chen Y, Ding C, Yu L, Guo W, Feng X, Su J, Xu T, Ren C, Shi D, Wu W, Yi P, Liu J, Tao J, Lang G, Li Y, Xu M, Sheng J,Li L, Xu K. One-year follow-up of chest CT findings in patients after SARS-CoV-2 infection.

2021; 19: 191[PMID: 34365975 DOI: 10.1186/s12916-021-02056-8]

6 Liu C, Ye L, Xia R, Zheng X, Yuan C, Wang Z, Lin R, Shi D, Gao Y, Yao J, Sun Q, Wang X, Jin M. Chest Computed Tomography and Clinical Follow-Up of Discharged Patients with COVID-19 in Wenzhou City, Zhejiang, China.

2020; 17: 1231-1237 [PMID: 32692945 DOI: 10.1513/AnnalsATS.202004-324OC]

7 Liu M, Lv F, Huang Y, Xiao K. Follow-Up Study of the Chest CT Characteristics of COVID-19 Survivors Seven Months After Recovery.

2021; 8: 636298 [PMID: 33732719 DOI: 10.3389/fmed.2021.636298]